UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000032480
Receipt No. R000037037
Scientific Title Valuable screening test to determine the cause of uveitis using aqueous humor
Date of disclosure of the study information 2018/12/01
Last modified on 2019/11/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Valuable screening test to determine the cause of uveitis using aqueous humor
Acronym Screening for aqueous humor
Scientific Title Valuable screening test to determine the cause of uveitis using aqueous humor
Scientific Title:Acronym Screening for aqueous humor
Region
Japan

Condition
Condition uveitis
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the pathogen and the cytokine in aqueous humor from uveitis patients qualitatively and quantitatively, comparing to control from cataract patients
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Levels of DNA of pathogen and cytokine in aqueous humor from patients that may induce or be relevant to uveitis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria uveitis
Key exclusion criteria none
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Masahiro
Middle name
Last name Zako
Organization Asai hospital
Division name Department of Ophthalmology
Zip code 4890866
Address 178-1 Yakata-cho, Seto, Aichi
TEL 0561843111
Email mzako@aol.com

Public contact
Name of contact person
1st name Masahiro
Middle name
Last name Zako
Organization Asai hospital
Division name Department of Ophthalmology
Zip code 4890866
Address 178-1 Yakata-cho, Seto, Aichi
TEL 0561843111
Homepage URL
Email mzako@aol.com

Sponsor
Institute Asai hospital
Institute
Department

Funding Source
Organization Asai hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Asai hospital
Address 178-1 Yakata-cho, Seto, Aichi
Tel 0561843111
Email kowa_ahp.mgr@gctv.ne.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 06 Month 01 Day
Date of IRB
Anticipated trial start date
2016 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Most appropriate treatment for uveitis patients is considered depending on the observational results of this screening

Management information
Registered date
2018 Year 05 Month 06 Day
Last modified on
2019 Year 11 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037037

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.